Lupin informs about press release

28 Dec 2020 Evaluate

Lupin has informed that it has enclosed a Press Release on 28th December 2020 as regards the launch by the Company of Meloxicam Capsules, 5 mg, and 10 mg, having received an approval from the US FDA, titled ‘Lupin launches Meloxicam Capsules’.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2124.65 -26.40 (-1.23%)
01-Feb-2026 14:39 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.80
Dr. Reddys Lab 1199.65
Cipla 1325.70
Zydus Lifesciences 887.35
Lupin 2124.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×